WST
West Pharmaceutical Services Inc
Price:  
215.82 
USD
Volume:  
858,026.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WST EV/EBITDA

-25.4%
Upside

As of 2025-06-22, the EV/EBITDA ratio of West Pharmaceutical Services Inc (WST) is 20.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WST's latest enterprise value is 15,309.27 mil USD. WST's TTM EBITDA according to its financial statements is 747.40 mil USD. Dividing these 2 quantities gives us the above WST EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.6x - 12.9x 12.8x
Forward P/E multiples 11.9x - 13.8x 13.2x
Fair Price 133.82 - 193.36 161.09
Upside -38.0% - -10.4% -25.4%
215.82 USD
Stock Price
161.09 USD
Fair Price

WST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-20 20.48
2025-06-18 20.69
2025-06-17 20.70
2025-06-16 21.30
2025-06-13 21.07
2025-06-12 21.36
2025-06-11 21.27
2025-06-10 21.63
2025-06-09 21.25
2025-06-06 21.34
2025-06-05 20.75
2025-06-04 20.06
2025-06-03 19.99
2025-06-02 19.87
2025-05-30 20.01
2025-05-29 19.97
2025-05-28 20.06
2025-05-27 20.02
2025-05-23 19.50
2025-05-22 19.78
2025-05-21 19.82
2025-05-20 20.45
2025-05-19 20.62
2025-05-16 20.56
2025-05-15 19.99
2025-05-14 19.61
2025-05-13 20.49
2025-05-12 20.83
2025-05-09 20.22
2025-05-08 20.38
2025-05-07 20.23
2025-05-06 19.48
2025-05-05 20.02
2025-05-02 20.05
2025-05-01 19.95
2025-04-30 20.05
2025-04-29 20.26
2025-04-28 20.51
2025-04-25 20.36
2025-04-24 19.98
2025-04-23 20.71
2025-04-22 20.42
2025-04-21 19.53
2025-04-17 19.15
2025-04-16 19.84
2025-04-15 20.16
2025-04-14 20.18
2025-04-11 19.99
2025-04-10 19.32
2025-04-09 19.30